Loading...
Loading...
India's clonazepam imports from CANADA total $1.1K across 15 shipments from 3 foreign suppliers. GLOBYZ PHARMA leads with $691 in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include LINCOLN PHARMACEUTICALS LTD. This corridor reflects India's pharmaceutical import demand for clonazepam — a concentrated sourcing relationship with select suppliers from CANADA.

GLOBYZ PHARMA is the leading Clonazepam supplier from CANADA to India, with import value of $691 across 8 shipments. The top 5 suppliers — GLOBYZ PHARMA, AURO PHARMA INC, CANADA, AURO PHARMA INC., CANADA — collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | GLOBYZ PHARMA | $691 | 8 | 62.2% |
| 2 | AURO PHARMA INC, CANADA | $229 | 1 | 20.6% |
| 3 | AURO PHARMA INC., CANADA | $190 | 6 | 17.2% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | LINCOLN PHARMACEUTICALS LTD | $691 | 8 | 62.2% |
| 2 | AUROBINDO PHARMA LTD | $419 | 7 | 37.8% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Clonazepam suppliers from CANADA to India include GLOBYZ PHARMA, AURO PHARMA INC, CANADA, AURO PHARMA INC., CANADA. The leading supplier is GLOBYZ PHARMA with import value of $691 USD across 8 shipments. India imported Clonazepam worth $1.1K USD from CANADA in total across 15 shipments.
India imported Clonazepam worth $1.1K USD from CANADA across 15 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Clonazepam sourced from CANADA include LINCOLN PHARMACEUTICALS LTD, AUROBINDO PHARMA LTD. The largest buyer is LINCOLN PHARMACEUTICALS LTD with $691 in imports across 8 shipments.
The total value of Clonazepam imports from CANADA to India is $1.1K USD, across 15 shipments and 3 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
15 Verified Shipments
3 suppliers, 2 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists